Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Checkpoint Inhibitors (ICIs)”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Not applicableLooking for participantsNCT05967910
What this trial is testing

The Effect of Chronic Stress on Efficacy of ICIs in Esophageal Cancer Patients (STRESS-ESCA Study)

Who this might be right for
Esophageal CancerImmunotherapy
Second Xiangya Hospital of Central South University 200
Not applicableStudy completedNCT05942872
What this trial is testing

CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival.

Who this might be right for
Paraneoplastic Syndromes
Hospices Civils de Lyon 90
Large-scale testing (Phase 3)UnknownNCT06031597
What this trial is testing

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Who this might be right for
Non-small Cell Lung Cancer Stage III
Zhejiang Cancer Hospital 105
Very early researchLooking for participantsNCT06329908
What this trial is testing

DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs

Who this might be right for
Lung Cancer
Zhen-Yu Ding 20
Not applicableWithdrawnNCT05292443
What this trial is testing

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

Who this might be right for
Primary Liver CancerHepatocellular CarcinomaIntrahepatic Cholangiocarcinoma+1 more
Geneplus-Beijing Co. Ltd.
Testing effectiveness (Phase 2)Looking for participantsNCT06413017
What this trial is testing

Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure

Who this might be right for
HCC
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05824481
What this trial is testing

Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Sun Yat-sen University 32
Testing effectiveness (Phase 2)UnknownNCT04826406
What this trial is testing

Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint Inhibitors
Hunan Cancer Hospital 40
Not applicableLooking for participantsNCT05718492
What this trial is testing

The Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 100
Not applicableStudy completedNCT04352335
What this trial is testing

Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator

Who this might be right for
Advanced Lung Cancer
Chung Shan Medical University 53
Not applicableActive Not RecruitingNCT06518018
What this trial is testing

Efficacy and Safety of High-Dose Rate Brachytherapy With Immunotherapy and Chemotherapy as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Stage NSCLCSecond-line TreatmentPatients Without Targetable Driver Mutations
The First People's Hospital of Neijiang 80
Not applicableUnknownNCT04492969
What this trial is testing

Prospective Observation of Failure Patterns in NSCLC Treated With ICIs

Who this might be right for
NSCLC Stage IVNSCLC, Recurrent
Fudan University 320
Testing effectiveness (Phase 2)Looking for participantsNCT07157969
What this trial is testing

ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital 300
Not applicableUnknownNCT05420922
What this trial is testing

Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC

Who this might be right for
Hepatocellular CarcinomaProgrammed Cell Death 1Effects of Immunotherapy
Tongji Hospital 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT06951646
What this trial is testing

CtDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

Who this might be right for
Non Small Cell Lung CancerImmune Checkpoint Inhibitors (ICIs)
Second Xiangya Hospital of Central South University 70
Not applicableUnknownNCT05821751
What this trial is testing

The Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint Inhibitors

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fondazione del Piemonte per l'Oncologia 40
Not applicableLooking for participantsNCT05862259
What this trial is testing

A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies

Who this might be right for
Malignant TumorImmunotherapyArtificial Intelligence
Xinqiao Hospital of Chongqing 120
Not applicableStudy completedNCT05688046
What this trial is testing

Efficacy and Safety Analysis of ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced NSCLC in Elderly Patients

Who this might be right for
NSCLC
Suzhou Municipal Hospital 79
Testing effectiveness (Phase 2)Looking for participantsNCT06675201
What this trial is testing

Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Neoantigen-loaded Dendritic Cell VaccineImmune Checkpoint Inhibitors (ICIs)
Sichuan University 165
Large-scale testing (Phase 3)Ended earlyNCT04985136
What this trial is testing

Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Jiangsu HengRui Medicine Co., Ltd. 1
Load More Results